Dexmedetomidine is Associated with Reduced In-Hospital Mortality Risk of Patients with Subarachnoid Hemorrhage Undergoing Surgery
Dexmedetomidine is associated with significantly lower in-hospital mortality in patients with SAH. These findings underscore the importance of sedative choice for patients with SAH, suggesting that dexmedetomidine could enhance patient outcomes.
Authors
- Ying Liu (ORCID: https://orcid.org/0000-0003-0165-8157)
- Yuanhui Zhang (ORCID: https://orcid.org/0000-0002-6021-0582)
- Jiao Peng (ORCID: https://orcid.org/0000-0002-8119-8893)
- Haitao Liu (ORCID: https://orcid.org/0000-0002-7840-3753)
Institutions
- Fujian Medical University (CN)
- Leshan Normal University (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- World Neurosurgery
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1016/j.wneu.2024.11.122
- Citations
- 4
- Primary Topic
- Intensive Care Unit Cognitive Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.69